🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07575256
Starting soon Not applicable

Multicenter Clinical Study on Robotic-Assisted Surgical Management of Posterior Cruciate Ligament Tibial Avulsion Fractures

NCT07575256 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Tsinghua Chang Gung Hospital
Phase
Not applicable
Started
2026-05-10
Last updated
2026-05-08

Condition(s) studied

PCL - Posterior Cruciate Ligament DeficiencyPosterior Cruciate Ligament TearPCL - Posterior Cruciate Ligament Rupture

Investigational drug(s) / intervention(s)

Surgical robot-assisted arthroscopic surgeryOpen reduction and internal fixation surgery

Surgical robot-assisted arthroscopic surgery: Experimental group: Robot-assisted arthroscopic surgery

Open reduction and internal fixation surgery: Control group: incisional reduction and internal fixation surgery

Study summary

The primary objective of this clinical trial is to evaluate the efficacy of robotic-assisted surgery in the management of posterior cruciate ligament (PCL) avulsion fractures involving the tibial insertion site of the cruciate ligament. Specifically, the study seeks to determine: (1) whether robotic-assisted surgery yields superior anatomical reduction accuracy-particularly in restoring the native position of the tibial avulsion fragment-compared with conventional open reduction and internal fixation (ORIF); and (2) whether such improved precision translates into enhanced long-term functional recovery of the knee joint.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Acute closed tibial avulsion fracture, with surgery performed within 3 weeks of injury ③ Radiographically confirmed Meyers-McKeever classification Type II or III fracture ④ Absence of absolute contraindications to surgical intervention ⑤ Provision of voluntary, written informed consent prior to enrollment Exclusion Criteria: * Pathological fractures or complex ipsilateral injuries, including concomitant fractures at other anatomical sites. * Prior ipsilateral knee joint surgery. ③. Significant vascular or neurological compromise. * Acute meniscal tears, acute anterior cruciate ligament (ACL) ruptures, or acute injuries to the medial or lateral collateral ligaments. * Compromised local soft tissue integrity, including open fractures. ⑥. Withdrawal from the study or loss to follow-up despite having provided written informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Tsinghua Changgung Hospital Beijing Beijing Municipality

More Beijing Tsinghua Chang Gung Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07575256 on ClinicalTrials.gov ↗ ← All trials in China